- Molecular NameMetronidazole
- SynonymMethronidazole; Metronidazol; Metronidazole Benzoate; Metronidazole Hcl; Metronidazole in Plastic Container; Metronidazolo
- Weight171.156
- Drugbank_IDDB00916
- ACS_NO443-48-1
- Show 2D model
- LogP (experiment)-0.1262
- LogP (predicted, AB/LogP v2.0)-0.07
- pka2.5
- LogD (pH=7, predicted)-0.07
- Solubility (experiment)9.41 mg/ml
- LogS (predicted, ACD/Labs)(ph=7)-0.7
- LogSw (predicted, AB/LogsW2.0)19.99
- Sw (mg/ml) (predicted, ACD/Labs)34.36
- No.of HBond Donors1
- No.of HBond Acceptors6
- No.of Rotatable Bonds3
- TPSA86.88
- StatusFDA approved
- Administrationoral, topical, rectal, IV, vaginal
- PharmacologyA nitroimidazole anti-infective medication used mainly in the treatment of infections caused by susceptible organisms, particularly anaerobic bacteria and protozoa.
- Absorption_value99.0
- Absorption (description)N/A
- Caco_2N/A
- Bioavailability99.0
- Protein binding11.0
- Volume of distribution (VD)0.74 L/kg
- Blood/Plasma Partitioning ratio (D_blood)N/A
- MetabollsmHepatic
- Half life8.5 h
- ExcretionRenal (60-80%), biliary (6–15%)
- Urinary Excretion10
- Clerance1.3 ml/min/kg
- ToxicityConvulsive seizures and peripheral neuropathy, the latter characterized mainly by numbness or paresthesia of an extremity
- LD50 (rat)LD50=500 mg/kg/day
- LD50 (mouse)LD50=3800